Emerging Roles of Malaysian Pharmacists in Asthma Management Amidst the COVID-19 Pandemic: A Narrative Review
- PMID: 37655143
- PMCID: PMC10467601
- DOI: 10.21315/mjms2023.30.4.4
Emerging Roles of Malaysian Pharmacists in Asthma Management Amidst the COVID-19 Pandemic: A Narrative Review
Abstract
The arrival of COVID-19 pandemic in March 2020 adversely affected every aspect of human life, including the management of asthma. The pandemic has forced clinicians to revisit the application of high-risk aerosol-generating procedures in asthma management, including spirometry and nebuliser therapy. The use of commercial spacers with pressurised metered-dose inhalers to replace nebulisation is limited by the high cost and pandemic-induced stock unavailability of these inhalers. The need for social distancing, healthcare reserves reallocation, and scarce personal protective equipment has promote increased telemedicine uptake for patients' asthma control and monitoring. Malaysian pharmacists have been providing long-term care of asthma through the introduction of the respiratory Medication Therapy Adherence Clinic (MTAC) to empower patients' general health literacy, train and regularly evaluate their inhalation technique, and reinforce the importance of medication compliance. To minimise the use of unplanned healthcare resources and avoidable COVID-19 infection exposure, Malaysian pharmacists need to better support asthma self-management via increased uptake of written Asthma Action Plans (AAPs). Pharmacist-led asthma treatment step-down to attain the lowest effective dose of inhaled corticosteroids (ICS) has become increasingly relevant during the pandemic, as its prolonged use carries risk of numerous side effects and possible hospitalisation. Telepharmacy offers a promising model for exploration and an alternative to the traditional service delivery of asthma education. Despite not being authorised as vaccinators, Malaysian pharmacists hold strong positions in COVID-19 immunisation programmes for pharmacovigilance and advocacy. The pandemic demands an increased role for pharmacists within medication management to prevent patients from the stockpiling that can cause adverse effects on pharmaceutical supply chain. This review intends to summarise the impact of COVID-19 on asthma management, with a focus on the transitional roles of Malaysian pharmacists before and after the pandemic era.
Keywords: COVID-19; Malaysia; SARS-CoV-2; asthma; pharmacists.
© Penerbit Universiti Sains Malaysia, 2023.
Conflict of interest statement
Conflict of Interest None.
Similar articles
-
Knowledge that people with intellectual disabilities have of their inhaled asthma medications: messages for pharmacists.Int J Clin Pharm. 2016 Feb;38(1):135-43. doi: 10.1007/s11096-015-0217-x. Epub 2015 Nov 11. Int J Clin Pharm. 2016. PMID: 26560115
-
Patients' Habits and the Role of Pharmacists and Telemedicine as Elements of a Modern Health Care System during the COVID-19 Pandemic.J Clin Med. 2021 Sep 17;10(18):4211. doi: 10.3390/jcm10184211. J Clin Med. 2021. PMID: 34575322 Free PMC article.
-
Aerosol delivery systems for treating obstructive airway diseases during the SARS-CoV-2 pandemic.Intern Emerg Med. 2021 Nov;16(8):2035-2039. doi: 10.1007/s11739-021-02812-x. Epub 2021 Jul 30. Intern Emerg Med. 2021. PMID: 34331192 Free PMC article. Review.
-
Pharmaceutical care to hospital outpatients during the COVID-19 pandemic. Telepharmacy.Farm Hosp. 2020 Jun 13;44(7):61-65. doi: 10.7399/fh.11498. Farm Hosp. 2020. PMID: 32533674 English.
-
Recommendations and guidance for providing pharmaceutical care services during COVID-19 pandemic: A China perspective.Res Social Adm Pharm. 2021 Jan;17(1):1819-1824. doi: 10.1016/j.sapharm.2020.03.012. Epub 2020 Mar 26. Res Social Adm Pharm. 2021. PMID: 32249102 Free PMC article. Review.
References
-
- Global Initiative for Asthma (GINA) Global strategy for asthma management and prevention (updated 2020) [Internet] 2020. [Retrieved 2021 Mar 12]. Available at: www.ginasthma.org.
-
- National Institute of Health (MOH) National Health and Morbidity Survey 2011. 2011 [Retrieved 2023 July 6]. Available at: https://iku.moh.gov.my/images/IKU/Document/REPORT/NHMS2011-VolumeIII.pdf.
-
- Lai CKW, Kim YY, Kuo SH, Spencer M, Williams AE. Cost of asthma in the Asia-Pacific region. Eur Respir Rev. 2006;15(98):10–16. doi: 10.1183/09059180.06.00009802. - DOI
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous